Comparison of perioperative indicators and 1-year follow-up outcomes between radical prostatectomy conducted within 2 weeks versus no earlier than 4 weeks after prostate biopsy
AINIWAER Kulaixi1,LI Qianyue2,LU Wenbo3,WUPUER Kadier4,AIKESHANJIANG Ailiyaer1, DONG Guofan1 ,HAN Feng1 ,WANG Yunze1 ,SUN Jianwei1 ,WANG Wenguang1 (1.Department of Urology,The First Afiliated Hospital of Xinjiang Medical University,Urumqi 830054; 2.Department of Urology,Xinjiang Production and Construction Corps Hospital,Urumqi 830092; 3.Department of Urology,Changji Branch of the First Afiliated Hospital of Xinjiang Medical University, Changji 8300ll; 4.Department of Urology,Central Hospital of Hami,Hami 839000,China)
ABSTRACT:ObjectiveTo analyze the impact of the interval time(IT)between prostate biopsy(PB)and radical prostatectomy(RP)on the perioperative safetyand prognostic efficacyof prostate cancer patients.MethodsAretrospective analysis was performedon87 patients whounderwent extraperitoneallaparoscopicRPatour hospitals duringJun.2O22 to Nov. 2024.The patients were divided into the IT?2 weeks group ( n=42 )and the IT?4 weeks group ( n=45 ) according to the interval betweenPBandRP.Baselinedata,perioperativeindicators,postoperativeinflammatory factors,postoperative pathological results,urinary continence,andcomplication rates were compared between the two groups.ResultsNo statisticallysignificantdifferences wereobservedbetweenthetwogroups inbaselineinformationoperationtimintraoperative blood loss,,intraoperative transfusionrate,postoperative hospital stay,catheterremoval time,inflammatoryfactorsand complications (Pgt;0.05) . Pathological results showed no significant differences in cancer tissue proportion,positive rate of lymph node,positive rate of surgical margins,and postoperative Gleason scores ( Pgt;0.05 ).However,the IT?2 weeks group exhibited significantly fewer cases of perineural invasion ( 25νs : 36,59.52% vs. 80.00% )and vascular invasion(5 vs. 12, 11.90% vs. 26.67% ) compared to the IT?4 weeks group ( ?Plt;0.05? . There were no significant differences in postoperative urinary control rate and prostate-specific antigen (PSA) level between the two groups ( Pgt;0.05 .ConclusionRadical prostatectomy performed ?2 weeks after prostate biopsy demonstrates better safety and prognosis.
KEY WORDS: prostate biopsy; laparoscopic radical prostatectomy; prostate cancer; operation timing
中圖分類號:R737.25 文獻標志碼:A DOI:10.3969/j.issn.1009-8291.2025.08.003
前列腺癌(prostatecancer,PCa)是男性泌尿生殖系統中最常見的惡性腫瘤之一,發病率居全球男性惡性腫瘤第2位,僅次于肺癌[1。前列腺穿刺活檢術(prostatebiopsy,PB)是公認的診斷PCa的“金標準”。前列腺癌根治術(radicalprostatectomy,RP)是局限性PCa的最佳治療選擇[2]。目前,對于PB術后行RP的手術間隔時間(surgicalintervaltime,IT)尚無明確共識。傳統觀點認為,PB術后 4~6 周待局部炎癥和水腫消退后再進行RP手術,有助于降低手術難度,減少并發癥發生風險[3]。然而,長時間等待可能導致腫瘤進展,加重患者心理負擔,且不同手術時機對患者圍手術期指標及術后1年功能恢復、腫瘤學結局的影響尚未達成共識。鑒于此,本文回顧性比較PB術后 ?2 周與PB術后 ?4 周行RP的圍手術期安全性及預后療效,以期為PB術后行RP的時間選擇提供參考。
1資料與方法
1.1 一般資料 回顧性分析2022年6月—2024年
11月于新疆醫科大學第一附屬醫院、新疆生產建設兵團醫院、新疆醫科大學第一附屬醫院昌吉分院、新疆哈密市中心醫院接受經腹膜外腹腔鏡RP患者的臨床資料。納入標準: ① 經直腸穿刺活檢確診為PCa; ② PB術后 ?2 周或 ?4 后行RP; ③ 預期壽命長且健康狀況允許手術; ④ 經腹膜外途徑行腹腔鏡RP手術; ⑤ 年齡 lt;75 歲; ⑥ 無其他手術禁忌證。排除標準: ① 穿刺至手術前接受內分泌治療、放化療等特殊治療; ② 術后易失訪; ③ 合并其他惡性腫瘤; ④ 既往下腹部正中切口手術; ⑤ 既往接受經尿道前列腺電切術(transurethrue resection ofprostate,TURP)。
經納入及排除標準篩選,最終選擇87例患者為研究對象。根據PB與RP間隔時間分為 IT?2 周組(2 (n=42),IT?4 周組( Δn=45 。兩組患者年……